Oct. 18, 2021

CEO of Major Defense Contractor Charged with Bribery

The chief executive officer (CEO) of Multinational Logistics Services (MLS}, a large ship husbanding company that has received over $1 billion in U.S. Navy contracts since 2010, appeared in the United States today to face a criminal charge for his alleged participation in a bribery scheme.

Oct. 18, 2021

DOJ and CEO of defunct medical testing laboratory settle False Claims Act and Anti-Kickback Statute civil case

A False Claims Act/Anti-Kickback Statute civil matter was resolved today with an agreed $1.1 million payment by the former Chief Executive Officer of a now defunct medical testing lab, announced U.S. Attorney Nicholas W. Brown. Jae Lee, 50, of Bellevue, Washington, served as the CEO of Northwest Physicians Laboratory (NWPL) from January 1, 2013, until July 30, 2015. Lee has agreed to pay $500,000 within 30 days of the settlement agreement, with additional payments annually until full payment is made.

Oct. 14, 2021

U.S. Attorney Announces Four Additional Enforcement Actions as Part of Data-Driven National Effort to Combat P-Stim Fraud Scheme and Recover Millions

Acting United States Attorney Jennifer Arbittier Williams announced three settlements and the filing of a complaint under the False Claims Act in the Eastern District of Pennsylvania. These are the latest actions in the national investigation into the scheme of improper billing involving P-Stim electroacupuncture devices. P-Stim is also branded as, among other things, ANSiStim, Stivax, NeuroStim, and NSS-2 Bridge.

Oct. 13, 2021

Connecticut Employment Contractor Pays $600K to Resolve Federal False Claims Act Allegations

The United States Attorney's Office today announced that it has entered into a settlement agreement with New Britain-based CW Resources Inc. to resolve allegations that CW Resources submitted claims that falsely certified compliance with program requirements and failed to maintain adequate medical documentation of significantly disabled employees pursuant to the AbilityOne Program.

Oct. 13, 2021

Lawrence Man Sentenced for Defense Contracting Fraud

A Lawrence man was sentenced yesterday in connection with a scheme to defraud the U.S. Navy relating to glove liners purchased for use on nuclear submarines.

Oct. 6, 2021

Crane company agrees to pay more than $4.5M to resolve lawsuit for non-compliance with Military Specifications

Crane Company has agreed to pay to the United States to resolve allegations it violated the False Claims Act (FCA) by failing to comply with Military Specification (Mil Spec) Mil-V 24624 for certain high performance butterfly valves and requirements for inclusion on the Qualified Products List (QPL) where the valves appeared. The valves were supplied for use in U.S. Navy ships.

Oct. 6, 2021

Former Rogers Company Executive Pleads Guilty To Role In Workers’ Comp Billing Fraud/Kickback Conspiracy

A former executive with a Rogers medical supply and billing company pleaded guilty today to one count of conspiracy to commit mail fraud, wire fraud, health care fraud, fraud to obtain federal employees’ compensation, and illegal remunerations (paying kickbacks), in connection with a scheme to defraud the U.S. government and private insurance companies by over-billing for unnecessary medications provided to workers’ compensation patients.

Oct. 5, 2021

Pharmacist Sentenced to Nearly 6 Years in Prison for Multimillion-Dollar Compounded Medicine Scam that Defrauded Health Care Plans

An Orange County pharmacist has been sentenced to 70 months in federal prison for submitting more than $13 million in claims for medically unnecessary compounded medication prescriptions, the Justice Department announced today.

Oct. 4, 2021

Government Contractor Agrees to Pay More Than $1 Million to Resolve False Claims Act Lawsuit for Overbilling in Federal Contracts

Airbus U.S. Space & Defense Inc., formerly known as Airbus Defense and Space Inc. (ADSI), has agreed to pay to the United States $1,043,475 to resolve allegations that it violated the False Claims Act by billing impermissible fees in contracts with a number of federal agencies.

Oct. 1, 2021

Pharmaceutical Companies Pay Over $400 Million to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drugs

Three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, have agreed to pay a total of $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs. These conspiracies allegedly resulted in higher drug prices for federal health care programs and beneficiaries according to the Justice Department.